Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
2023 · New England Journal of Medicine · 626 citations
https://doi.org/10.1056/nejmoa2302312
E
Eugenia Girda
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
138
Papers
1.9K
Citations
18
h-index
30
i10-index
Eugenia Girda is an academic researcher from Rutgers, The State University of New Jersey. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Endometrial and Cervical Cancer Treatments & Cancer Immunotherapy and Biomarkers. The author has an h-index of 18, co-authored 118 publications.
ORCID: 0000-0002-4787-5475Papers by this author
worksCervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement
2023 · Gynecologic Oncology · 22 citations
https://doi.org/10.1016/j.ygyno.2023.10.017
HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy
2022 · Gynecologic Oncology · 19 citations
https://doi.org/10.1016/j.ygyno.2022.09.006
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors
2025 · Clinical Cancer Research · 10 citations
https://doi.org/10.1158/1078-0432.ccr-24-4280
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)
2025 · Clinical Cancer Research · 9 citations
https://doi.org/10.1158/1078-0432.ccr-24-3128
Vaginal mucositis related to immunotherapy in endometrial cancer
2021 · Gynecologic Oncology Reports · 4 citations
https://doi.org/10.1016/j.gore.2021.100742
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat